Heart disease is the primary cause of death in the United States, and most heart disease can be attributed to coronary artery atherosclerosis. Low HDL-cholesterol is an independent risk factor for coronary artery disease and myocardial infarction. One protective role of HDL is as a mediator of reverse cholesterol transport. Apolipoprotein A-l (apoAl) is the major protein constituent of HDL. ABCA1 is required for apoAl lipidation and the genesis of HDL, as demonstrated by the absence of apoAl lipidation in Tangier disease subjects who have defective ABCA1 and enhanced cardiovascular disease risk. The objectives of this proposal are to understand the mechanism by which ABCA1 mediates the binding of and lipid efflux to apoAl, and apoAl structural features that enable it to act as a lipid acceptor. Achieving the aims of this proposal will allow us to have a more detailed understanding of the process of lipid efflux and HDL biogenesis, and may have an impact on the emerging field of therapeutics designed to raise HDL levels for the treatment and prevention of coronary artery disease.
The first aim i s to determine the changes in the plasma membrane mediated by ABCA1 that allow recognition by apoAl. This involves lipid, protein, and biophysical studies of the plasma membrane, and liposome studies.
The second aim i s to understand the role of endocytosis in lipid efflux and the mechanism of assembly of the nascent lipoprotein. This involves inhibition of endocytosis by genetic methods, time course studies of apoAl uptake and release, testing a novel model for lipid assembly onto apoAl, and identification of apoAl binding sites on ABCA1.
The third aim i s to determine structural features of apoAl and model peptides that are required for them to function as acceptors of cellular lipids. This involves studying the role of helix unfolding and the role of the positivelycharged residues in lipid binding and acceptor activity. In addition, this study will include the identification of the apoAl oxidative modification by the enzyme myeloperoxidase that diminishes its lipid acceptor activity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL066082-06
Application #
7101790
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Wassef, Momtaz K
Project Start
2000-12-01
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
6
Fiscal Year
2006
Total Cost
$377,173
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Malik, Priya; Berisha, Stela Z; Santore, Jennifer et al. (2011) Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport. J Lipid Res 52:951-7
Lyssenko, Nicholas N; Brubaker, Gregory; Smith, Bradley D et al. (2011) A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells. Arterioscler Thromb Vasc Biol 31:2700-6
Smith, Jonathan D (2010) Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis. Curr Opin Investig Drugs 11:989-96
Smith, Jonathan D (2010) Dysfunctional HDL as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol 30:151-5
Smith, Jonathan D (2010) Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. J Clin Lipidol 4:382-8
Robinet, Peggy; Wang, Zeneng; Hazen, Stanley L et al. (2010) A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells. J Lipid Res 51:3364-9
Undurti, Arundhati; Huang, Ying; Lupica, Joseph A et al. (2009) Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 284:30825-35
Velez-Carrasco, Wanda; Merkel, Martin; Twiss, Christian O et al. (2008) Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J Nutr Biochem 19:362-70
Peng, Dao-Quan; Brubaker, Gregory; Wu, Zhiping et al. (2008) Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function. Arterioscler Thromb Vasc Biol 28:2063-70
Wu, Zhiping; Wagner, Matthew A; Zheng, Lemin et al. (2007) The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat Struct Mol Biol 14:861-8

Showing the most recent 10 out of 21 publications